- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sartorius Stedim Biotech SA (STDM)
Sartorius Stedim Biotech SA stock price live, this page displays EPA STDM stock exchange data. View the STDM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sartorius Stedim Biotech SA real time stock price chart below.
What Is the Sartorius Stedim Biotech SA Stock Price Today?
The Sartorius Stedim Biotech SA stock price today is 214.30.
What Is the Stock Symbol for Sartorius Stedim Biotech SA?
The stock symbol for Sartorius Stedim Biotech SA is "STDM."
What Stock Exchange Does Sartorius Stedim Biotech SA Trade On?
Sartorius Stedim Biotech SA is listed and trades on the Paris stock exchange.
Is Sartorius Stedim Biotech SA a Good Stock to Buy?
Determining whether Sartorius Stedim Biotech SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STDM quote. (ISIN: FR0013154002)
What Is the Sartorius Stedim Biotech SA Stock Price Today?
The Sartorius Stedim Biotech SA stock price today is 214.30.
What Is the Stock Symbol for Sartorius Stedim Biotech SA?
The stock symbol for Sartorius Stedim Biotech SA is "STDM."
What Stock Exchange Does Sartorius Stedim Biotech SA Trade On?
Sartorius Stedim Biotech SA is listed and trades on the Paris stock exchange.
Is Sartorius Stedim Biotech SA a Good Stock to Buy?
Determining whether Sartorius Stedim Biotech SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the STDM quote. (ISIN: FR0013154002)
214.30
-6.40(-2.90%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
213.50
219.30
52 wk Range
148.75
239.80
STDM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
213.50219.30
52 wk Range
148.75239.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
STDM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
243.77
Upside
+13.75%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Stedim receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Sartorius Stedim Biotech SA Company Profile
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Compare STDM to Peers and Sector
Metrics to compare | STDM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTDMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 79.0x | 32.1x | −0.6x | |
PEG Ratio | 1.29 | 1.31 | 0.00 | |
Price/Book | 5.2x | 4.5x | 2.6x | |
Price / LTM Sales | 7.1x | 4.8x | 3.3x | |
Upside (Analyst Target) | 14.8% | 14.1% | 40.0% | |
Fair Value Upside | Unlock | −3.9% | 3.2% | Unlock |
Analyst Ratings
10 Buy
3 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 243.77
(+13.75% Upside)
Earnings
Latest Release
Oct 16, 2025
EPS / Forecast
0.94 / 0.9816
Revenue / Forecast
705.70M / 696.97M
FAQ
What Is the Sartorius Stedim (STDM) Stock Price Today?
The Sartorius Stedim stock price today is 214,30
What Stock Exchange Does Sartorius Stedim Trade On?
Sartorius Stedim is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Sartorius Stedim?
The stock symbol for Sartorius Stedim is "STDM."
Does Sartorius Stedim Pay Dividends? What’s The Current Dividend Yield?
The Sartorius Stedim dividend yield is 0.32%.
What Is the Sartorius Stedim Market Cap?
As of today, Sartorius Stedim market cap is 20.85B.
What Is Sartorius Stedim's Earnings Per Share (TTM)?
The Sartorius Stedim EPS (TTM) is 2.71.
When Is the Next Sartorius Stedim Earnings Date?
Sartorius Stedim will release its next earnings report on 02 Feb 2026.
From a Technical Analysis Perspective, Is STDM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Sartorius Stedim Stock Split?
Sartorius Stedim has split 7 times.
How Many Employees Does Sartorius Stedim Have?
Sartorius Stedim has 10134 employees.
What is the current trading status of Sartorius Stedim (STDM)?
As of 10 Jan 2026, Sartorius Stedim (STDM) is trading at a price of 214,30, with a previous close of 220,70. The stock has fluctuated within a day range of 213,50 to 219,30, while its 52-week range spans from 148,75 to 239,80.
What Is Sartorius Stedim (STDM) Price Target According to Analysts?
The average 12-month price target for Sartorius Stedim is EUR243.76923, with a high estimate of EUR275 and a low estimate of EUR218. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +13.75% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.